Tag: Disease-modifying antirheumatic drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Disease-modifying antirheumatic drugs

Methotrexate and Hydroxychloroquine Combo may significantly Improve Outcomes in ...

Added to Collection on: 2024-09-13 15:15:54

Tags for this article:

Disease-modifying antirheumatic drugs
Autoimmune diseases
Rheumatology
Connective tissue diseases
Immunosuppressants
Methotrexate
Rheumatoid arthritis
C-reactive protein
Arthritis
Hydroxychloroquine
Tumor necrosis factor
Sjögren syndrome

Click the tags to see associated articles and topics

View Article Details
Higher Risk of Interstitial Lung Disease in Patients With RA, PsA Initiating bDMARDs

Added to Collection on: 2024-09-13 19:47:17

Tags for this article:

Autoimmune diseases
Arthritis
Rheumatology
Immunosuppressants
Disease-modifying antirheumatic drugs
Methotrexate
Rheumatoid arthritis
Psoriatic arthritis
Interstitial lung disease

Click the tags to see associated articles and topics

View Article Details
Etanercept Biosimilar Insight Market Report 2024: Pipeline

Added to Collection on: 2024-09-19 14:24:15

Tags for this article:

Immunosuppressants
Disease-modifying antirheumatic drugs
TNF inhibitors
Arthritis
Autoimmune diseases
Etanercept
Biosimilar
Biopharmaceutical
Spondyloarthritis
Rheumatoid arthritis
Psoriasis
Psoriatic arthritis

Click the tags to see associated articles and topics

View Article Details
Lilly touts Omvoh's superiority over J&J's Stelara in Crohn's - Clinical Trials Arena

Added to Collection on: 2024-10-15 14:33:59

Tags for this article:

Autoimmune diseases
Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Abdominal pain
Biosimilar
Adalimumab
Crohn's disease
Inflammatory bowel disease
Eli Lilly and Company
Ulcerative colitis
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight

Added to Collection on: 2024-10-23 15:17:12

Tags for this article:

Monoclonal antibodies
Arthritis
Disease-modifying antirheumatic drugs
Biotechnology
Immunosuppressants
Spondyloarthritis
Certolizumab pegol
Axial spondyloarthritis
Bimekizumab
Ankylosing spondylitis
Biopharmaceutical
Ixekizumab
Eli Lilly and Company
Janssen Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions

Added to Collection on: 2024-10-31 13:05:31

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Pharmacy
Biosimilar
Biopharmaceutical
Psoriasis
Adalimumab
Ustekinumab
Etanercept
Amgen
Robert Popovian
United States
Stelara

Click the tags to see associated articles and topics

View Article Details
Biosimilars Month in Review: October 2024 - HCPLive

Added to Collection on: 2024-11-02 18:03:59

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Janssen Biotech
Biosimilar
Adalimumab
Infliximab
Ustekinumab
Etanercept
Ulcerative colitis
Crohn's disease

Click the tags to see associated articles and topics

View Article Details
Alopecia - Current Treatment - Treatment Algorithms: Claims Data Analysis - Alopecia Areata (US)

Added to Collection on: 2024-11-01 21:05:33

Tags for this article:

Hair diseases
Human hair
Disease-modifying antirheumatic drugs
Autoimmune diseases
Alopecia areata
Janus kinase inhibitor
Hair loss
Baricitinib
Tofacitinib

Click the tags to see associated articles and topics

View Article Details
Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies

Added to Collection on: 2024-12-14 22:31:52

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Disease-modifying antirheumatic drugs
Janssen Biotech
Orphan drugs
Ustekinumab
Vedolizumab
Infliximab
Adalimumab
Immunoglobulin E
Hypersensitivity
Alpha-gal syndrome

Click the tags to see associated articles and topics

View Article Details
Biologics Market Size to Worth USD 1,044.2 Million By 2031 - BioSpace

Added to Collection on: 2025-01-02 23:09:02

Tags for this article:

Biotechnology
Biotechnology products
Disease-modifying antirheumatic drugs
Immunosuppressants
Biopharmaceuticals
Biosimilar
AstraZeneca
Vaccine
Novartis
Eli Lilly and Company
Food and Drug Administration
Merck & Co.

Click the tags to see associated articles and topics

View Article Details